Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $87.68 million. The enterprise value is $159.85 million.
| Market Cap | 87.68M |
| Enterprise Value | 159.85M |
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 69.59 million shares outstanding. The number of shares has increased by 71.10% in one year.
| Current Share Class | 69.59M |
| Shares Outstanding | 69.59M |
| Shares Change (YoY) | +71.10% |
| Shares Change (QoQ) | +1.21% |
| Owned by Insiders (%) | 21.68% |
| Owned by Institutions (%) | 33.64% |
| Float | 30.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | 0.53 |
| PB Ratio | 6.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 5.01.
| Current Ratio | 1.67 |
| Quick Ratio | 1.04 |
| Debt / Equity | 5.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.31 |
Financial Efficiency
Return on equity (ROE) is -131.56% and return on invested capital (ROIC) is -16.16%.
| Return on Equity (ROE) | -131.56% |
| Return on Assets (ROA) | -13.56% |
| Return on Invested Capital (ROIC) | -16.16% |
| Return on Capital Employed (ROCE) | -29.87% |
| Weighted Average Cost of Capital (WACC) | 9.04% |
| Revenue Per Employee | $230,450 |
| Profits Per Employee | -$56,403 |
| Employee Count | 658 |
| Asset Turnover | 1.13 |
| Inventory Turnover | 17.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.27% in the last 52 weeks. The beta is 1.04, so Neuronetics's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -63.27% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 45.64 |
| Average Volume (20 Days) | 1,450,731 |
Short Selling Information
The latest short interest is 9.88 million, so 14.20% of the outstanding shares have been sold short.
| Short Interest | 9.88M |
| Short Previous Month | 9.64M |
| Short % of Shares Out | 14.20% |
| Short % of Float | 32.21% |
| Short Ratio (days to cover) | 3.21 |
Income Statement
In the last 12 months, Neuronetics had revenue of $151.64 million and -$37.11 million in losses. Loss per share was -$0.55.
| Revenue | 151.64M |
| Gross Profit | 73.12M |
| Operating Income | -29.02M |
| Pretax Income | -37.23M |
| Net Income | -37.11M |
| EBITDA | -25.78M |
| EBIT | -29.02M |
| Loss Per Share | -$0.55 |
Balance Sheet
The company has $13.21 million in cash and $85.39 million in debt, with a net cash position of -$72.17 million or -$1.04 per share.
| Cash & Cash Equivalents | 13.21M |
| Total Debt | 85.39M |
| Net Cash | -72.17M |
| Net Cash Per Share | -$1.04 |
| Equity (Book Value) | 17.06M |
| Book Value Per Share | 0.19 |
| Working Capital | 18.89M |
Cash Flow
In the last 12 months, operating cash flow was -$12.80 million and capital expenditures -$779,000, giving a free cash flow of -$13.58 million.
| Operating Cash Flow | -12.80M |
| Capital Expenditures | -779,000 |
| Depreciation & Amortization | 3.24M |
| Net Borrowing | 4.79M |
| Free Cash Flow | -13.58M |
| FCF Per Share | -$0.20 |
Margins
Gross margin is 48.22%, with operating and profit margins of -19.14% and -24.48%.
| Gross Margin | 48.22% |
| Operating Margin | -19.14% |
| Pretax Margin | -24.55% |
| Profit Margin | -24.48% |
| EBITDA Margin | -17.00% |
| EBIT Margin | -19.14% |
| FCF Margin | n/a |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -71.10% |
| Shareholder Yield | -71.10% |
| Earnings Yield | -42.33% |
| FCF Yield | -15.49% |
Analyst Forecast
The average price target for Neuronetics is $4.33, which is 243.65% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.33 |
| Price Target Difference | 243.65% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 9.87% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -3.58 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.58 |
| Piotroski F-Score | 2 |